Basic Information
Basic information for MIR9-3HG-225-36aa
Peptide Name MIR9-3HG-225-36aa
Genome Position chr15:89395298-89395405[+]
Species Human
Peptide Sequence MYPNPSLKGLCLWPIGLASTSSPCLFLSHLVRSVWV
Peptide Length 36
Unique No (MIR9-3HG-201-36aa-1,MIR9-3HG-202-36aa,MIR9-3HG-203-36aa,MIR9-3HG-205-36aa,MIR9-3HG-212-36aa-1,MIR9-3HG-213-36aa-1,MIR9-3HG-214-36aa-2,MIR9-3HG-218-36aa-2,MIR9-3HG-219-36aa-2,MIR9-3HG-220-36aa-1,MIR9-3HG-221-36aa-1,MIR9-3HG-222-36aa-2,MIR9-3HG-224-36aa,MIR9-3HG-226-36aa-1,MIR9-3HG-227-36aa-2,MIR9-3HG-228-36aa,MIR9-3HG-229-36aa,MIR9-3HG-233-36aa-2,MIR9-3HG-240-36aa,MIR9-3HG-241-36aa-2,MIR9-3HG-242-36aa,MIR9-3HG-244-36aa,MIR9-3HG-246-36aa-2,MIR9-3HG-247-36aa-1,MIR9-3HG-248-36aa,MIR9-3HG-249-36aa,MIR9-3HG-251-36aa-2,MIR9-3HG-252-36aa-2,MIR9-3HG-253-36aa-2)
Grand Average of Hydropathicity 0.675
Relative Molecular Mass 4604.28
Experimental Evidences 2:m6A,ribo
lncRNA ID/Name ENSG00000255571;MIR9-3HG
Transcript ID/Name ENST00000660922;MIR9-3HG-225
Transcript Length 1827
Coding Ability 0.5369
DNA Sequence Corresponding to Peptide ATGTACCCCAACCCATCCCTTAAGGGCCTTTGTCTTTGGCCCATTGGCCTAGCATCTACTTCTTCACCGTGTCTGTTCTTGTCACACCTAGTCAGGTCTGTTTGGGTC
Experimental Evidences
   m6A
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :